Related Experiment Video
Updated: Jun 19, 2026
08:48
Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Paula I Moreira1, Cristina Carvalho, Xiongwei Zhu
1Center for Neuroscience and Cell Biology, Institute of Physiology-Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Biochimica Et Biophysica Acta
|October 27, 2009
Summary
Mitochondrial dysfunction is an early factor in Alzheimer's disease, impacting neuronal survival. Enhancing autophagy may offer new therapeutic strategies for this neurodegenerative condition.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Mitochondria regulate neuronal energy metabolism and cell death pathways.
- Mitochondrial dysfunction and oxidative damage are implicated in Alzheimer's disease (AD) pathogenesis.
- Autophagy degrades damaged cellular components and protein aggregates.
Purpose of the Study:
- To review the early and significant role of mitochondrial dysfunction in Alzheimer's disease.
- To explore the connection between mitochondrial dysfunction and autophagy in AD.
- To discuss autophagy as a potential therapeutic target for AD.
Main Methods:
- Review of existing scientific literature.
- Analysis of evidence linking mitochondrial dysfunction to AD.
- Discussion of the role of autophagy in AD pathophysiology.
Main Results:
- Mitochondrial dysfunction plays an early and critical role in Alzheimer's disease.
- Impaired autophagy leads to the accumulation of lipofuscin, exacerbating neuronal dysfunction.
- Autophagy is crucial for clearing damaged macromolecules and organelles.
Conclusions:
- Mitochondrial dysfunction is a key early event in Alzheimer's disease.
- Defective autophagy contributes to neurodegeneration in AD by preventing clearance of cellular damage.
- Targeting autophagy presents a promising therapeutic avenue for Alzheimer's disease.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...